1,260 results on '"Schnabel, Renate B."'
Search Results
202. Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries
203. Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study
204. Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?
205. The Association of Periodontitis and Peripheral Arterial Occlusive Disease in a Prospective Population-Based Cross-Sectional Cohort Study
206. Alcohol and atrial fibrillation: dose matters, not so much the type
207. Non-immune risk predictors of cardiac allograft vasculopathy: Results from the U.S. organ procurement and transplantation network
208. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) : the Task Force for the diagnosis and management of atrialfibrillation of the European Society of Cardiology (ESC) : developed with the special contribution of the European HeartRhythm Association (EHRA) of the ESC
209. Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death
210. Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality
211. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
212. Cardiac Troponin I and Incident Stroke in European Cohorts : Insights From the BiomarCaRE Project
213. Rationale and Design of the Hamburg City Health Study
214. Cardiac Troponin I and Incident Stroke in European Cohorts:Insights From the BiomarCaRE Project
215. Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality
216. Neues beim Schlaganfall – Teil 1: Akuttherapie
217. Digital, risk-based screening for atrial fibrillation in the European community—the AFFECT-EU project funded by the European Union
218. Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device
219. Heart and brain interactions
220. Research Priorities in Atrial Fibrillation Screening
221. Risk prediction of atrial fibrillation in the community combining biomarkers and genetics
222. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes
223. Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study
224. Genetic and Clinical Predictors of Left Atrial Thrombus: A Single Center Case-Control Study
225. World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update
226. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality
227. Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia
228. Risk assessment for incident heart failure in individuals with atrial fibrillation
229. Midregional pro-atrial natriuretic peptide in the general population/Insights from the Gutenberg Health Study
230. Predicting the future in patients with atrial fibrillation: who develops heart failure?
231. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
232. A multiple biomarker risk score for guiding clinical decisions using a decision curve approach
233. Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies
234. Improving the Prediction of Incident Atrial Fibrillation—Reply
235. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference
236. Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration
237. Atrial fibrillation: villain or bystander in vascular brain injury
238. No impact of sex and age on beta‐adrenoceptor‐mediated inotropy in human right atrial trabeculae
239. Diversity 4.0 in the cardiovascular health-care workforce
240. Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry
241. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
242. Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation
243. Epidemiology of Atrial Fibrillation in the 21st Century
244. Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death
245. Cardio‐Renal Biomarker Soluble Urokinase‐Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C‐Reactive Protein, and Renal Function
246. White Blood Cells and Blood Pressure
247. Tissue-specific multiOMICs analysis of atrial fibrillation
248. Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease
249. Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis
250. Multiple marker approach to risk stratification in patients with stable coronary artery disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.